German government pushing ahead with cannabis legalisation

The German health minister is pressing ahead with plans to legalise cannabis, despite concerns from some quarters that it could be challenged at the EU level, and unresolved questions about what the regulatory framework will look like. HBI speaks to legal and policy experts, and hears that medical cannabis producers have an early adopter advantage against potential rivals - and there are health implications if legislation passes.

Interview: Joe Stringer, partner, Octopus Ventures

Joe Stringer, healthcare investment specialist, and partner at Octopus Ventures which invests in and supports start-up businesses across Europe, talks to HBI about his approach to investment ahead of his panel appearance at HBI 2022.

Proposed EU data sharing framework ‘will save €11bn’

The European Commission has put forward a proposal for a new legal framework to regulate the sharing of health data across the EU which it says could save the healthcare sector €11bn over ten years. The proposal is subject to review by the European Council and Parliament but could come into force in 2025.

Bupa Australia accuses Ramsay of strategic price hikes as Ramsay terminates partnership

The Australian branch of multinational hospital giant Ramsay Health Care has terminated its partnership with insurer Bupa, meaning Bupa-insured patients in Australia will have to pay out-of-pocket for its care. Bupa Australia subsequently accused Ramsay of “unreasonably high" price increases, claiming this was done to increase the group’s value in light of its on-going sale process. Meanwhile, Ramsay has reported poor financial results and analysts from investment bank Citigroup have said limited additional value could be squeezed out of the group, and that a higher bid than KKR's is therefore unlikely. 

Lusiadas Saude sale latest

HBI hears that there has been progress in the sale of Lusiadas Saude, Portugal’s third-largest hospital group by revenue.

Find Us